| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 19,525 | 23,699 | 23,576 | 21,883 | | Cost of Revenue | 19,280 | 19,198 | 18,469 | 13,060 | | | Gross Profit | 245 | 4,501 | 5,107 | 8,823 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,897 | 3,224 | 3,000 | 8,234 | | Non Recurring |
-
|
-
|
-
| 2,494 | | Others | 296 | 293 | 287 | 282 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,948) | 984 | 1,820 | (2,187) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (60) | (49) | (58) | 32 | | Earnings Before Interest And Taxes | (3,008) | 935 | 1,762 | (2,155) | | Interest Expense | 522 | 561 | 584 | 900 | | Income Before Tax | (3,530) | 374 | 1,178 | (3,055) | | Income Tax Expense |
-
| (1,859) | 448 | 2,835 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,530) | 2,233 | 730 | (5,890) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,530) | 2,233 | 730 | (5,890) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,530) | $2,233 | $730 | ($5,890) |
|
0.26% Nasdaq 
Income Statement
